Related Experiment Videos
Hypercorticism--a risk factor in arterial hypertension and atherosclerosis
Endocrinologie
|April 1, 1981
Summary
Hypercorticism can cause arterial hypertension and metabolic disorders, even in young patients, increasing atherosclerosis risk. Managing excess adrenal hormones can resolve these conditions, particularly in those without prior heart issues.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Hypercorticism is increasingly recognized as a potential risk factor for cardiovascular diseases.
- Arterial hypertension and atherosclerosis are significant global health concerns with multifactorial origins.
- Glucidic and lipidic metabolic disorders are established contributors to cardiovascular pathology.
Purpose of the Study:
- To analyze the role of hypercorticism as a risk factor in arterial hypertension and atherosclerosis.
- To investigate the incidence of cardiovascular disorders in relation to age and metabolic disturbances.
- To evaluate the impact of managing hypercorticism on associated cardiovascular and metabolic conditions.
Main Methods:
- Analysis of a cohort of 149 patients (male and female) of various ages.
- Assessment of cardiovascular disorders, including arterial hypertension.
- Investigation of glucidic and lipidic metabolic profiles in relation to hypercorticism.
Main Results:
- Hypercorticism can precipitate arterial hypertension and glucidic-lipid metabolic disorders, even in very young individuals.
- These metabolic disturbances are implicated as risk factors for atherosclerosis.
- Hypercorticism exacerbates pre-existing cardiopathy.
Conclusions:
- Hypercorticism is a significant risk factor for arterial hypertension and metabolic disorders, contributing to atherosclerosis.
- Effective management of excess adrenocortical hormones leads to complete resolution of arterial hypertension and metabolic disorders.
- Treatment is particularly effective in young patients and adults without prior cardiovascular complaints.